WASHINGTON -- Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug ...

This class of drugs has a growing list of beneficial applications beyond just treating type 2 diabetes, Billingsley noted, but their cost can be a barrier for many people to access them.

A large study of older women suggests metformin may increase the chance of living to age 90. Scientists are increasingly ...

Medicaid plans often put up barriers around newer classes of diabetes medications ... as having at least one medication in each class listed on the preferred drug list without prior authorization ...

The Food and Drug Administration (FDA) has added more medicines for cancer, diabetes, high cholesterol, hypertension, and ...

This is just one of a growing list of diseases and conditions Ozempic ... “It’s exciting that these diabetes medications may offer additional benefits, such as protecting brain health ...

The supply of GLP-1 drugs like Ozempic has been increasing, but they’re still expensive for most patients. Here are answers ...